Table 2.
Parameter | Distribution |
---|---|
Accrual rate | Year 1: 5000 |
Year 2: 25 000 | |
Year 3: 20 000 | |
Year 4: 15 000 | |
Randomization | 1: 1 |
Proportion in each risk strata | Low risk: 28.9 |
Average risk: 40.4% | |
Elevated risk: 28.2% | |
High risk: 2.5% | |
Annual hazard for mammogram detected cancer | Low risk: 0.0198 |
Average risk: 0.0414 | |
Elevated risk: 0.0774 | |
High risk: 0.2808 | |
Median time from mammogram to clinically detectable cancer | 18 months |
Noncompliance time | Normal+ (0, 4 months) |
Mammographic sensitivity | 100% |
(Low risk: 93% | |
Average risk: 86% | |
Elevated risk: 76% | |
High risk: 86% | |
used in sensitivity analyses) | |
Percent with prevalent stage IIB | 0.05% |
Total trial time | 4.5 y |